IRCT2015101411819N3已完成2 期
Evaluation the Effect of Silymarin on Inflammatory Markers in Comparison with Placebo in ß-thalassemia Patients undergoing Iron Chelation Therapy
Vice chancellor for research, Mazandaran University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Patients with beta thalassemia major; History of iron chelation therapy for at least 2 years; Having relatively constant average dose of iron chelation during 3 months ago; Ferritin up to 1000 µg/L
- •Exclusion criteria: Change therapeutic regimen with iron chelation during the study (6 months)
排除标准
- 未提供
研究者
相似试验
已完成
4 期
The effect of silymarin on Alzheimer’s diseasesAlzheimer disease.Alzheimer's diseaseIRCT20131219015870N3Faculty of Pharmaceutical Sciences, Islamic Azad University of Medical Sciences, Tehran22
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60
尚未招募
3 期
Effect of silymarin in inflammatory bowel diseaseK50-K52Inflammatory Bowel Disease.Noninfective inflammatory bowel diseaseIRCT20101107005123N3Mashhad University of Medical Sciences40
已完成
Unknown
Effect of Simiaosan on Inflammatory Factors and Uric Acid Levels in Gout Patients with Damp-Heat Blockage SyndromeGoutITMCTR2024000227Quzhou Hospital of Traditional Chinese Medicine